Overview
Scientists at the University of Utah’s Natural History Museum are investigating a little‑known Chinese mushroom, Lanmaoa asiatica, after dozens of consumers reported strikingly similar “lilliputian” hallucinations when the fungus is eaten raw. Test subjects describe seeing miniature, cartoon‑clad figures marching across tablecloths, swimming in soup bowls and clinging to spoons – a visual motif that has appeared in anecdotal reports for centuries. The team’s goal is to isolate the unidentified compound responsible, determine its pharmacology, and assess whether it might have therapeutic value or pose a public‑health risk.
Research Findings
Lead investigator Colin Domnauer, a doctoral candidate in biology, says the consistency of the visions is unusual for naturally occurring psychedelics. “When we compiled the first set of testimonies, the pattern was unmistakable: tiny people appearing on everyday objects, often interacting with food,” he explained. Laboratory analysis confirmed that the hallucinations occur only when the mushrooms are consumed raw; cooking the same specimens eliminates the effect, suggesting the active molecule is heat‑labile. Preliminary animal studies indicate the compound can produce psychoactive episodes lasting up to three days, with occasional cases requiring hospital observation for dehydration and disorientation.
Historical Context
The phenomenon mirrors “lilliputian hallucinations” described in folklore and early ethnobotanical literature. Mycologist Giuliana Furci, founder of the Fungi Foundation, notes that 19th‑century travelers in Yunnan Province documented similar visions, yet the species remained unidentified for decades. “People have been searching for a mushroom that makes you see tiny people for generations, but they never found the species,” Furci said, referencing a recent BBC Future feature. The new research therefore bridges a gap between historic accounts and modern neuropharmacology, adding L. asiatica to a short list of substances—such as psilocybin and ibogaine—that produce distinct visual motifs across cultures.
Potential Applications and Risks
If the active molecule can be isolated, researchers speculate it could expand the toolbox for treating conditions like depression, anxiety, or post‑traumatic stress disorder, where controlled psychedelic experiences have shown promise. However, the long duration of the trips and reports of hospitalizations underscore safety concerns. “We are proceeding with caution,” Domnauer emphasized. The team is collaborating with toxicologists to establish dosage thresholds, metabolic pathways, and possible contraindications, especially given the compound’s apparent resistance to degradation by heat or standard cooking methods.
Next Steps
The Utah team plans to publish a detailed chemical profile later this year and to begin Phase I clinical trials under FDA oversight, contingent on successful animal safety data. Parallel ethnographic work in Yunnan aims to document traditional preparation methods that may inadvertently neutralize the psychoactive component. As the investigation progresses, public health officials are advised to issue warnings about consuming raw Lanmaoa asiatica, while the scientific community watches closely for insights that could illuminate both human consciousness and the broader pharmacology of hallucinogenic fungi.
